Observational studyCNS drugs2021

Safety, Patient-Reported Well-Being, and Physician-Reported Assessment of Walking Ability in Patients with Multiple Sclerosis for Prolonged-Release Fampridine Treatment in Routine Clinical Practice: Results of the LIBERATE Study.

Giovanni Castelnovo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.